Nonsense Mutation
3 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Phase 2 Study of ELX-02 in Patients With Nephropathic Cystinosis (NCT04069260) | Eloxx Pharmaceuticals, Inc. | 2019-08-02 |
| Phase 1 Study of ELX-02 in Healthy Adult Subjects (NCT03309605) | Eloxx Pharmaceuticals, Inc. | 2017-10-11 |
| Phase 1 Study of ELX-02 in Healthy Adults (NCT03292302) | Eloxx Pharmaceuticals, Inc. | 2017-09-26 |
Track Nonsense Mutation automatically
Every clearance here is in the API, with alerts when new ones post.